Analysis of 35,213 patients with stage II-III colon cancer revealed that recurrence risk drops below 0.5% at 6 years post-surgery, supporting a practical definition of cure. Women showed a ...
Defining cure in stage II and III colon cancer has been challenging, and has never been systematically studied. In an analysis of 15 randomized trials, colon cancer relapse risk fell to 0.5% by year 6 ...
A pooled analysis of randomized trials in colon cancer identified a benchmark representing a "clinically relevant definition of cure," researchers said. Looking at 15 phase III trials, colon cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results